Institutional investors purchased a net $1.9 million shares of CGIX during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 17.97% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STONEPINE CAPITAL MANAGEMENT LLC Bought 1.8 Million shares of Cancer Genetics Inc
PERKINS CAPITAL MANAGEMENT, INC. Bought 183.0 Thousand shares of Cancer Genetics Inc
THE VANGUARD GROUP, INC. Bought 70.9 Thousand shares of Cancer Genetics Inc